MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610. (Q38442004)
Jump to navigation
Jump to search
scientific article published on September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610. |
scientific article published on September 2005 |
Statements
1 reference
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610. (English)
1 reference
Li-Yan Khor
1 reference
Michelle Desilvio
1 reference
Tahseen Al-Saleem
1 reference
M Elizabeth Hammond
1 reference
David J Grignon
1 reference
William Sause
1 reference
Michael Pilepich
1 reference
Paul Okunieff
1 reference
Howard Sandler
1 reference
Alan Pollack
1 reference
Radiation Therapy Oncology Group
1 reference
1 September 2005
1 reference
1 reference
104
1 reference
5
1 reference
962-967
1 reference
1 reference
Identifiers
1 reference
1 reference